Gordon E. Crofoot, MD

The Crofoot Research Center, Houston, TX, USA

Disclosure(s): Gilead Sciences, Inc.: Grant/Research Support

Poster(s):

• (P-365) Pooled safety and tolerability of twice-yearly lenacapavir with teropavimab and zinlirvimab for HIV-1 treatment
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET